News A re-brand for US generics and biosimilars sector Body will campaign to "Keep Medicines in Reach"
News NICE rejects second Alexion ultra-rare disease drug NHS will not fund Kanuma for rare disease LAL-D.
News Norgine rejoins ABPI after eight year absence ABPI says Norgine's support will be important during Brexit.
News Acacia ready to file its anti-vomiting treatment Potential launch in 2018 if FDA approves Baremsis.
News Biotech leaders unite against Trump travel ban Spokesman also causes confusion over pricing policy.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
